Substance with
unlimited potential

Our flagship product is the highest quality soudium hyaluronate and its functional derivates. In crafting new products, we tap into the latest knowledge, right from the basic research stage.

Strong & stable background

Our company is built on the systematically interfused pillars of active ingredients, pharmaceutical products and devices. We are global leaders in the realm of physical chemistry and biology of Hyaluronan.

Avoiding bulls
in a china shop

We believe that everybody can live better and longer, but not twice. It’s fair to care. We endorse activities engaging civil society and special interest associations in our region.
Hyaluronan as the key to our portfolio
Contipro holding merged to public limited company


Contipro Group s.r.o. and Contipro Biotech s.r.o. were wounded up, leaving Contipro Pharma a.s. as the sole legal successor, which retained its existing registration number and the legal form of a public limited company.
The company name was shortened to Contipro a.s. All liabilities and other legal circumstances of all preceding companies continue to exist unchanged and are concentrated at Contipro a.s.

This merger doesn't impair the legal status of any creditors, business partners, employees or any other parties.
By 1st May 2016, we are not the holding anymore. Now we are Contipro, all together.
Notice for creditors and shareholders of the merging companies in czech (PDF)
Download detailed description of the merger in czech (PDF)

The story of „CONnective TIssue PROducts“
 
 

February, 1990

Contipro is born

Free market and private entrepreneurship come to Czechoslovakia and all six founders including the current CEO Dr. Velebný start developing biotechnological production in an ordinary blender as a first step towards their vision.

 

Hyaluronan with pharmaceutical quality

After years of production of nutritional supplements and cosmetic ingredients, Contipro enters pharmaceutical world.

July, 1998

 

November, 2000

Veterinary medication for joints

Bonharen is our first really successful final product. Nowadays, Bonharen is synonym for „veterinary joint treatment“ in central Europe.

 

Contipro enters human medicine market

In human pharmaceutical final products, Contipro is specialized in wound healing. Hyiodine becomes one of the most effective products on the market.

January, 2004

 

November, 2009

Opening new R&D centre

To reach our goals, we decide to build brand new R&D centre. Science is the very soul of Contipro.

Our R&D in numbers

0
Papers in peer reviewed
journals every year
0
Patents and Industrial
design rights
0
In-house researchers
and developers
0
Square meters of fully
equipped laboratories

Contact us

contipro on white

Contipro a.s.
Dolní Dobrouč 401
561 02 Dolní Dobrouč
Czech Republic

(+420) 465 519 530
(+420) 465 543 793

VAT CZ60917431

sales@contipro.com
info@contipro.com
Contipro France

Meet us

WBC Canada
Montreal
17-22th May, 2016

CPhI Korea
Seoul
23-25th August, 2016

in-cosmetics USA
New York
7-8th September, 2016

Europe map KW